{"id":"W802625524","doi":"10.1007/s10549-015-3466-4","title":"Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eisai; NSABP Foundation","keywords":"Medicine; Eribulin; Breast cancer; Anthracycline; Cyclophosphamide; Taxane; Capecitabine; Chemotherapy; Internal medicine; Neoadjuvant therapy; Oncology; Epirubicin; Surgery; Randomized controlled trial; Cancer; Metastatic breast cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002205654,0.002199463,0.0032043,0.000432557,0.000583309,0.001027892,0.001243846,0.001913238,0.01098172],"category_scores_gemma":[0.001883507,0.0009009053,0.001700311,0.0005456975,0.001629192,0.001202967,0.0005705977,0.003936293,0.002088436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001379359,"about_ca_system_score_gemma":0.002326876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002596127,"about_ca_topic_score_gemma":0.00652666,"domain_scores_codex":[0.9991766,0.0005053446,0.00003106704,0.0001362504,0.00003653011,0.0001141135],"domain_scores_gemma":[0.9983967,0.0004111906,0.0003374885,0.0001713976,0.00007433078,0.0006087343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9835224,0.008170055,0.0005366534,0.0001211404,0.0003447885,0.00001636128,0.00002373335,0.000303594,0.00166144,0.00005916232,0.0005860188,0.004654567],"study_design_scores_gemma":[0.943575,0.05369937,0.001492381,0.00001322074,0.0002382003,0.00001567369,0.00001989516,0.0001630172,0.0002091436,0.00007970096,0.000485666,0.000008781017],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824606,0.001795595,0.0008513111,0.001551236,0.0007485261,0.005906602,0.00332858,0.0001364885,0.003221113],"genre_scores_gemma":[0.9603844,0.002870472,0.003816045,0.002601893,0.0006187698,0.01387239,0.0057576,0.00008154834,0.009996893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01098172,"threshold_uncertainty_score":0.0367375,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05531339928623241,"score_gpt":0.4301154364575364,"score_spread":0.374802037171304,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}